Chemical and Pharmacological Studies on Enantiomerically Pure p‐Methoxytacripyrines, Promising Multi‐Target‐Directed Ligands for the Treatment of Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  ChemMedChem

• Publication date

  2011-11-04

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/cmdc.201100239PMID 21990269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

  2009cited by this paper
• Effect of chirality of small molecule organofluorine inhibitors of amyloid self-assembly on inhibitor potency.

  2009cited by this paper
• A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques.

  2009cited by this paper
• Amyloid (cid:1) -Protein Toxicity and the Pathogenesis of Alzheimer Disease

  2009cited by this paper
• Recent advances in the Friedländer reaction.

  2009cited by this paper
• Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.

  2009cited by this paper
• Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.

  2009cited by this paper
• Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates.

  2008cited by this paper
• Multi-target-directed ligands to combat neurodegenerative diseases.

  2008cited by this paper
• A small molecule targeting the multifactorial nature of Alzheimer's disease.

  2007cited by this paper
• Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease.

  2007cited by this paper
• Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of Action

  2007cited by this paper
• First gallamine-tacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor.

  2007cited by this paper
• N-Methylated Peptide Inhibitors of β-Amyloid Aggregation and Toxicity. Optimization of the Inhibitor Structure†

  2006cited by this paper
• Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase.

  2006cited by this paper
• CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

  2006cited by this paper
• Dimeric and hybrid anti-Alzheimer drug candidates.

  2006cited by this paper
• Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors.

  2006cited by this paper
• A Century of Alzheimer's Disease

  2006cited by this paper
• Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties.

  2006cited by this paper
• Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer's disease.

  2006cited by this paper
• Unequal Neuroprotection Afforded by the Acetylcholinesterase Inhibitors Galantamine, Donepezil, and Rivastigmine in SH-SY5Y Neuroblastoma Cells: Role of Nicotinic Receptors

  2005cited by this paper
• Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity.

  2004cited by this paper
• Treatment of Alzheimer's disease: current and future therapeutic approaches.

  2004cited by this paper
• A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.

  2003cited by this paper
• Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.

  2003cited by this paper
• beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies.

  2003cited by this paper
• Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products*

  2003cited by this paper
• Treatment of Alzheimer's disease: current status and new perspectives.

  2003cited by this paper
• Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.

  2003cited by this paper
• 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy.

  2003cited by this paper
• Ligand-receptor interaction at the neural nicotinic acetylcholine binding site: a theoretical model.

  2002cited by this paper
• Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.

  2002cited by this paper
• Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions.

  1999cited by this paper
• Effects of nicotinic receptor agonists on beta-amyloid beta-sheet formation.

  1999cited by this paper
• Brain Acetylcholinesterase Promotes Amyloid-β-Peptide Aggregation but Does Not Hydrolyze Amyloid Precursor Protein Peptides

  1998cited by this paper
• Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

  1996cited by this paper
• Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer's filaments.

  1996cited by this paper
• Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.

  1994cited by this paper
• Synthese von substituierten 2‐Aminonicotinonitrilen

  1994cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• Kinetic analysis of amyloid fibril polymerization in vitro.

  1991cited by this paper
• Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

  1986cited by this paper
• Synthesis of heterocyclic compounds. LI. Schiff bases of ethyl 2‐aminofurancarboxylates

  1986cited by this paper
• CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

  1983cited by this paper
• American Association of Colleges of Nursing and the Council of Baccalaureate and Higher Degree Programs: purposes, roles and relationships.

  1974cited by this paper
• Interaction between bisquaternary ammonium ligands and acetylcholinesterase: complex formation studied by fluorescence quenching.

  1974cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper
• Orthoesters and Related Compounds from Malono- and Succinonitriles

  1949cited by this paper
• Biological Crystallography Structures of Recombinant Native and E202q Mutant Human Acetylcholinesterase Complexed with the Snake-venom Toxin Fasciculin-ii

  year unknowncited by this paper

• Cholinesterase-based inhibitors as multitarget small molecules for the therapy of Alzheimer's disease.

  2025cites this paper
• Tacrine-Based Hybrids: Past, Present, and Future

  2023cites this paper
• Hydroxycoumarins and some flavonoids from Pistacia atlantica Desf. as multi-targets inhibitors for Alzheimer's disease: Molecular docking and ADMET studies.

  2022cites this paper
• SAR studies of quinoline and derivatives as potential treatments for Alzheimer’s disease

  2022cites this paper
• Synthesis and Cholinesterase Inhibitory Activity of N-Phosphorylated / N-Tiophosphorylated Tacrine.

  2020cites this paper
• Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease.

  2018cites this paper
• Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines.

  2018cites this paper
• 5-Methyl-N-(8-(5,6,7,8-tetrahydroacridin-9-ylamino)octyl)-5H-indolo[2,3-b]quinolin-11-amine: a highly potent human cholinesterase inhibitor.

  2017cites this paper
• Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy.

  2017cites this paper
• Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment.

  2016cites this paper
• Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride.

  2015cites this paper
• Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.

  2014cites this paper
• Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease.

  2014cites this paper
• Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease

  2014cites this paper
• Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease.

  2013cites this paper
• Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates.

  2013influential citation
• Synthesis, pharmacological assessment, and molecular modeling of acetylcholinesterase/butyrylcholinesterase inhibitors: effect against amyloid-β-induced neurotoxicity.

  2013cites this paper
• Multifunctional tacrine derivatives in Alzheimer's disease.

  2013cites this paper
• Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes

  2013cites this paper
• Novel racemic tetrahydrocurcuminoid dihydropyrimidinone analogues as potent acetylcholinesterase inhibitors.

  2013cites this paper
• Enantioselective Neuroprotective Effects of Tacripyrine ITH122 Against Oxygen and Glucose Deprivation in Rat Hippocampal Slices

  2013cites this paper
• Structure–Activity Relationships of Organofluorine Inhibitors of β‐Amyloid Self‐Assembly

  2012cites this paper
• La Escuela de Farmacología de Madrid de D. Teófilo Hernando a Instituto de I+D del medicamento de la Universidad Autónoma de Madrid

  2012cites this paper
• Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.

  2012cites this paper
• Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease.

  2012cites this paper